peoplePerson
Evanthia Galanis
Evanthia Galanis is a brain tumour specialist who chairs one of the largest US clinical trial networks.
Medical oncologist whose research centres on glioblastoma and oncolytic measles virus therapy. Became group chair of the Alliance in 2023, succeeding Monica Bertagnolli.
Role
Group Chair, Alliance for Clinical Trials in Oncology; Professor of Oncology, Mayo Clinic
Institution
Specialisms
Neuro-oncologyOncolytic virusesCooperative group trials
| Title | Journal | Year |
|---|---|---|
| Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer | Cancer Research | 2015 |
| Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study | Journal of Clinical Oncology | 2009 |
Pages like this
not linked directly; found by shared links- InstitutionDuke Cancer Institute
Shares Alliance for Clinical Trials in Oncology, Oncolytic viruses, Glioma & glioblastoma.
- IdeaDeliver drugs and cells to the brain through the nose
Shares Oncolytic viruses, Glioma & glioblastoma.
- InstitutionO'Neal Comprehensive Cancer Center at UAB
Shares Glioma & glioblastoma, Ovarian cancer.
- IdeaOne-two punch: clear senescent cells after chemotherapy
Shares Mayo Clinic, Ovarian cancer.
- InstitutionQIMR Berghofer Medical Research Institute
Shares Glioma & glioblastoma, Ovarian cancer.
- InstitutionThe Wistar Institute
Shares Glioma & glioblastoma, Ovarian cancer.
- IdeaMake every cold tumour hot: a coordinated programme to reprogramme immune-excluded tumours
Shares Oncolytic viruses, Ovarian cancer.
- IdeaA perpetual platform trial in every major cancer, funded as infrastructure
Shares Glioma & glioblastoma, Ovarian cancer.